119 results on '"Gabayet F"'
Search Results
2. Comparison of three scales (BIS, SUMD and BCIS) for measuring insight dimensions and their evolution after one-year of follow-up: Findings from the FACE-SZ Cohort
- Author
-
Aouizerate, B., Berna, F., Blanc, O., Capdevielle, D., Chereau-Boudet, I., Coulon, N., D'Amato, T., Dorey, J.M., Dubertret, C., Fond, G., Gabayet, F., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Passerieux, C., Pignon, B., Peri, P., Portalier, C., Rey, R., Roman, C., Schürhoff, F., Szöke, A., Urbach, M., Zinetti-Bertschy, A., Capdevielle, Delphine, Norton, Joanna, Aouizerate, Bruno, Berna, Fabrice, Chereau, Isabelle, D'Amato, Thierry, Dubertret, Caroline, Dubreucq, Julien, Fond, Guillaume, C, Lançon, Mallet, Jasmina, Misdrahi, David, Passerieux, Catherine, Rey, Romain, Schurhoff, Franck, Urbach, Mathieu, Llorca, Pierre-Michel, and Raffard, Stéphane
- Published
- 2021
- Full Text
- View/download PDF
3. Being parent is associated with suicidal history in people with serious mental illness enrolled in psychiatric rehabilitation
- Author
-
Dubreucq, M., Plasse, J., Gabayet, F., Blanc, O., Chereau, I., Cervello, S., Couhet, G., Demily, C., Guillard-Bouhet, N., Gouache, B., Jaafari, N., Legrand, G., Legros-Lafarge, E., Mora, G., Pommier, R., Quilès, C., Verdoux, H., Massoubre, C., Franck, N., and Dubreucq, J.
- Published
- 2021
- Full Text
- View/download PDF
4. Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset
- Author
-
Andrianarisoa, M.D., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, Jm, D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, Am, Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Pignon, Baptiste, Lajnef, Mohamed, Godin, Ophélia, Geoffray, Marie-Maud, Rey, Romain, Mallet, Jasmina, Dubertret, Caroline, Roux, Paul, Passerieux, Christine, Marulaz, Laurent, Brunel, Lore, Dubreucq, Julien, Leignier, Sylvain, Capdevielle, Delphine, André, Myrtille, Aouizerate, Bruno, Misdrahi, David, Berna, Fabrice, Vidailhet, Pierre, Chereau, Isabelle, Llorca, Pierre-Michel, Fond, Guillaume, Lançon, Christophe, Leboyer, Marion, and Schürhoff, Franck
- Published
- 2019
- Full Text
- View/download PDF
5. A multi-dimensional approach to the relationship between insight and aggressiveness in schizophrenia: Findings from the FACE-SZ cohort
- Author
-
Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, L., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Norton, J., Raffard, S., Rey, R., Schurhoff, F., and Bonnet, S.
- Published
- 2019
- Full Text
- View/download PDF
6. Psychiatric disability as mediator of the neurocognition-functioning link in schizophrenia spectrum disorders: SEM analysis using the Evaluation of Cognitive Processes involved in Disability in Schizophrenia (ECPDS) scale
- Author
-
Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, Jm, D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, Am, Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Roux, Paul, Urbach, Mathieu, Fonteneau, Sandrine, Berna, Fabrice, Brunel, Lore, Capdevielle, Delphine, Chereau, Isabelle, Dubreucq, Julien, Faget-Agius, Catherine, Fond, Guillaume, Leignier, Sylvain, Perier, Claire-Cécile, Richieri, Raphaëlle, Schneider, Priscille, Schürhoff, Franck, Tronche, Anne-Marie, Yazbek, Hanan, Zinetti-Bertschy, Anna, Passerieux, Christine, and Brunet-Gouet, Eric
- Published
- 2018
- Full Text
- View/download PDF
7. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort
- Author
-
Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Coulon, N., Danion, J.M., D'Amato, T., Deloge, A., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Jarroir, M., Leignier, S., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Boyer, L., Godin, O., and Chereau, I.
- Published
- 2018
- Full Text
- View/download PDF
8. Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort
- Author
-
Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, Jm, D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, Am, Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Boyer, L., Godin, O., Llorca, P.M., Chereau, I., Lancon, C., Roux, P., and Schürhoff, F.
- Published
- 2018
- Full Text
- View/download PDF
9. Towards an improved access to psychiatric rehabilitation: availability and effectiveness at 1-year follow-up of psychoeducation, cognitive remediation therapy, cognitive behaviour therapy and social skills training in the FondaMental Advanced Centers of Expertise-Schizophrenia (FACE-SZ) national cohort
- Author
-
Dubreucq, Julien, Ycart, B., Gabayet, F., Perier, C. C., Hamon, A., Llorca, P. M., Boyer, L., Godin, O., Bulzacka, E., Andrianarisoa, M., Aouizerate, B., Berna, F., Brunel, L., Capdevielle, D., Chereau, I., D’Amato, T., Dubertret, C., Faget, C., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Richieri, R., Schandrin, A., Schürhoff, F., Urbach, M., Vidailhet, P., Giraud-Baro, E., Fond, G., and FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
- Published
- 2019
- Full Text
- View/download PDF
10. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort
- Author
-
Mallet, J., Le Strat, Y., Schürhoff, F., Mazer, N., Portalier, C., Andrianarisoa, M., Aouizerate, B., Berna, F., Brunel, L., Capdevielle, D., Chereau, I., D’Amato, T., Dubreucq, J., Faget, C., Gabayet, F., Honciuc, R. M., Lançon, C., Llorca, P. M., Misdrahi, D., Rey, R., Roux, P., Schandrin, A., Urbach, M., Vidailhet, P., Fond, G., Dubertret, C., and the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
- Published
- 2019
- Full Text
- View/download PDF
11. Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort
- Author
-
Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilain, J., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Godin, O., Boyer, L., Richieri, R., and Costagliola, D.
- Published
- 2017
- Full Text
- View/download PDF
12. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort
- Author
-
Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Mazer, N., Chereau, I., and Roux, P.
- Published
- 2017
- Full Text
- View/download PDF
13. Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort
- Author
-
Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Boyer, L., Godin, O., Richieri, R., and Schürhoff, F.
- Published
- 2017
- Full Text
- View/download PDF
14. Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set
- Author
-
Fond, G., Bulzacka, E., Boyer, L., Llorca, P. M., Godin, O., Brunel, L., Andrianarisoa, M. G., Aouizerate, B., Berna, F., Capdevielle, D., Chereau, I., Denizot, H., Dorey, J. M., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Le Strat, Y., Micoulaud-Franchi, J. A., Misdrahi, D., Rey, R., Richieri, R., Roger, M., Passerieux, C., Schandrin, A., Urbach, M., Vidalhet, P., Schürhoff, F., Leboyer, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J. M., D’Amato, T., Deloge, A., Delorme, C., Denizot, H., De Pradier, M., Dorey, J. M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M. C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P. M., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, A. M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., and FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Group
- Published
- 2017
- Full Text
- View/download PDF
15. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort
- Author
-
Fond, G., Resseguier, N., Schürhoff, F., Godin, O., Andrianarisoa, M., Brunel, L., Bulzacka, E., Aouizerate, B., Berna, F., Capdevielle, D., Chereau, I., D’Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Lançon, C., Llorca, P. M., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Boyer, L., Leboyer, M., and the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
- Published
- 2018
- Full Text
- View/download PDF
16. Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia – Data from the FACE-SZ cohort
- Author
-
Szoke, Andrei, primary, Richard, Jean-Romain, additional, Fond, Guillaume, additional, Misdrahi, David, additional, Lajnef, Mohamed, additional, Aouizerate, Bruno, additional, Boyer, Laurent, additional, Berna, Fabrice, additional, Capdevielle, Delphine, additional, André, Myrtille, additional, Chereau, Isabelle, additional, Clauss-Kobayashi, Julie, additional, Coulon, Nathalie, additional, Dubertret, Caroline, additional, Leignier, Sylvain, additional, Llorca, Pierre Michel, additional, Mallet, Jasmina, additional, Passerieux, Christine, additional, Rey, Romain, additional, Schorr, Benoit, additional, Urbach, Mathieu, additional, Leboyer, Marion, additional, Pignon, Baptiste, additional, Schürhoff, Franck, additional, Andre, M., additional, Andrieu-Haller, C., additional, Aouizerate, B., additional, Berna, F., additional, Blanc, O., additional, Bourguignon, E., additional, Capdevielle, D., additional, Chereau-Boudet, I., additional, Clauss-Kobayashi, J., additional, Coulon, N., additional, Dassing, R., additional, Dorey, J.M., additional, Dubertret, C., additional, Esselin, A., additional, Fond, G., additional, Gabayet, F., additional, Jarroir, M., additional, Lacelle, D., additional, Leboyer, M., additional, Leignier, S., additional, Llorca, P.M., additional, Mallet, J., additional, Metairie, E., additional, Michel, T., additional, Misdrahi, D., additional, Passerieux, C., additional, Petrucci, J., additional, Pignon, B., additional, Peri, P., additional, Portalier, C., additional, Rey, R., additional, Roman, C., additional, Schorr, B., additional, Schürhoff, F., additional, Szoke, A., additional, Tessier, A., additional, Urbach, M., additional, Wachiche, G., additional, and Zinetti-Bertschy, A., additional
- Published
- 2023
- Full Text
- View/download PDF
17. Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia
- Author
-
Baudin, G., Godin, O., Lajnef, M., Aouizerate, B., Berna, F., Brunel, L., Capdevielle, D., Chereau, I., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fond, G., Gabayet, F., Laouamri, H., Lancon, C., Le Strat, Y., Tronche, A.M., Misdrahi, D., Rey, R., Passerieux, C., Schandrin, A., Urbach, M., Vidalhet, P., Llorca, P.M., and Schürhoff, F.
- Published
- 2016
- Full Text
- View/download PDF
18. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set
- Author
-
Fond, G., Godin, O., Brunel, L., Aouizerate, B., Berna, F., Bulzacka, E., Capdevielle, D., Chereau, I., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Le Strat, Y., Micoulaud-Franchi, J.A., Misdrahi, D., Rey, R., Richieri, R., Passerieux, C., Schandrin, A., Schürhoff, F., Tronche, A.M., Urbach, M., Vidalhet, P., Llorca, P.M., and Leboyer, M.
- Published
- 2016
- Full Text
- View/download PDF
19. Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset
- Author
-
Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., De Pradier, M., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilain, J., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Boyer, L., Chereau, I., and Lancon, C.
- Published
- 2015
- Full Text
- View/download PDF
20. Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort
- Author
-
Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Depradier, M., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Godin, O., Gaman, A., Chereau, I., Richieri, R., Vidalhet, P., and Girerd, N.
- Published
- 2015
- Full Text
- View/download PDF
21. Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset
- Author
-
Rey, Romain, D’Amato, Thierry, Boyer, Laurent, Brunel, Lore, Aouizerate, Bruno, Berna, Fabrice, Capdevielle, Delphine, Chereau, Isabelle, Chesnoy-Servanin, Gabrielle, Denizot, Hélène, Dorey, Jean-Michel, Dubertret, Caroline, Dubreucq, Julien, Faget, Catherine, Gabayet, Franck, Lancon, Christophe, Mallet, Jasmina, Misdrahi, David, Passerieux, Christine, Schandrin, Aurélie, Schürhoff, Franck, Urbach, Mathieu, Vidailhet, Pierre, Llorca, Pierre-Michel, Fond, Guillaume, Andrianarisoa, M., Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D’Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilain, J., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., and The FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
- Published
- 2017
- Full Text
- View/download PDF
22. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort
- Author
-
Fond, G., Berna, F., Andrianarisoa, M., Godin, O., Leboyer, M., Brunel, L., Aouizerate, B., Capdevielle, D., Chereau, I., D’Amato, T., Denizot, H., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Llorca, P. M., Mallet, J., Misdrahi, D., Passerieux, C., Richieri, R., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Boyer, L., Schürhoff, F., and The FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
- Published
- 2017
- Full Text
- View/download PDF
23. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set
- Author
-
Fond, Guillaume, Berna, F., Boyer, L., Godin, O., Brunel, L., Andrianarisoa, M., Aouizerate, B., Capdevielle, D., Chereau, I., Danion, J. M., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Le Gloahec, T., Llorca, P. M., Mallet, J., Misdrahi, D., Rey, R., Richieri, R., Passerieux, C., Portalier, C., Roux, P., Vehier, A., Yazbek, H., Schürhoff, F., Bulzacka, E., Andrianarisoa, Méja, Aouizerate, Bruno, Berna, Fabrice, Blanc, Olivier, Brunel, Lore, Bulzacka, Ewa, Capdevielle, Delphine, Chéreau-Boudet, Isabelle, Chesnoy-Servanin, Gabrielle, Danion, Jean-Marie, D’Amato, Thierry, Deloge, Arnaud, Delorme, Claire, Denizot, Hélène, Dorey, Jean-Michel, Dubertret, Caroline, Dubreucq, Julien, Faget, Catherine, Fluttaz, Cécile, Fond, Guillaume, Fonteneau, Sandrine, Gabayet, Franck, Giraud-Baro, Elisabeth, Hardy-Baylé, Marie-Christine, Lacelle, Delphine, Lançon, Christophe, Laouamri, Hakim, Leboyer, Marion, Le Gloahec, Tifenn, Le Strat, Yann, Llorca, Pierre-Michel, Mallet, Jasmina, Metairie, Emeline, Misdrahi, David, Offerlin-Meyer, Isabelle, Passerieux, Christine, Peri, Pauline, Pires, Sylvie, Portalier, Céline, Rey, Romain, Roman, Céline, Sebilleau, Mathilde, Schandrin, Aurélie, Schurhoff, Franck, Tessier, Arnaud, Tronche, Anne-Marie, Urbach, Mathieu, Vaillant, Florence, Vehier, Aurélie, Vidailhet, Pierre, Vilà, Estelle, Yazbek, Hanan, Zinetti-Bertschy, Anna, and The FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
- Published
- 2017
- Full Text
- View/download PDF
24. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset
- Author
-
Fond, G., Boyer, L., Favez, M., Brunel, L., Aouizerate, B., Berna, F., Capdevielle, D., Chereau, I., Dorey, J. M., Dubertret, C., Dubreucq, Faget, C., Gabayet, F., Laouamri, H., Lancon, C., Le Strat, Y., Misdrahi, D., Rey, R., Passerieux, C., Schandrin, A., Schurhoff, F., Tronche, A. M., Urbach, M., Vidalhet, P., Llorca, P. M., Pelissolo, A., and And the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group*
- Published
- 2016
- Full Text
- View/download PDF
25. Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort
- Author
-
Foiselle, Marianne, primary, Barbosa, Susana, additional, Godin, Ophélia, additional, Wu, Ching-Lien, additional, Boukouaci, Wahid, additional, Andre, Myrtille, additional, Aouizerate, Bruno, additional, Berna, Fabrice, additional, Barau, Caroline, additional, Capdevielle, Delphine, additional, Vidailhet, Pierre, additional, Chereau, Isabelle, additional, Davidovic, Laetitia, additional, Dorey, Jean-Michel, additional, Dubertret, Caroline, additional, Dubreucq, Julien, additional, Faget, Catherine, additional, Fond, Guillaume, additional, Leigner, Sylvain, additional, Llorca, Pierre-Michel, additional, Mallet, Jasmina, additional, Misdrahi, David, additional, Martinuzzi, Emanuela, additional, Passerieux, Christine, additional, Rey, Romain, additional, Pignon, Baptiste, additional, Urbach, Mathieu, additional, Schürhoff, Franck, additional, Glaichenhaus, Nicolas, additional, Leboyer, Marion, additional, Tamouza, Ryad, additional, Berna, F., additional, Haffen, E., additional, Leboyer, M., additional, Llorca, P.M., additional, Schürhoff, F., additional, Barteau, V., additional, Bensalem, S., additional, Godin, O., additional, Laouamri, H., additional, Souryis, K., additional, Offerlin-Meyer, I., additional, Pignon, B., additional, Szöke, A., additional, Aouizerate, B., additional, Deloge, A., additional, Misdrahi, D., additional, Vilà, E., additional, Blanc, O., additional, Chéreau, I., additional, Denizot, H., additional, Honciuc, R.M., additional, Lacelle, D., additional, Pires, S., additional, Dubertret, C., additional, Mallet, J., additional, Portalier, C., additional, Dubreucq, J., additional, Fluttaz, C., additional, Gabayet, F., additional, Roman, C., additional, Chesnoy-Servanin, G., additional, D'Amato, T., additional, Dorey, J.M., additional, Rey, R., additional, Vehier, A., additional, Lançon, C., additional, Faget, C., additional, Metairie, E., additional, Peri, P., additional, Vaillant, F., additional, Boyer, L., additional, Fond, G., additional, Vidailhet, P., additional, Zinetti-Bertschy, A., additional, Capdevielle, D., additional, Yazbek, H., additional, Esselin, S., additional, Jarroir, M., additional, Passerieux, C., additional, and Urbach, M., additional
- Published
- 2022
- Full Text
- View/download PDF
26. Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ)
- Author
-
Sunhary de Verville, Pierre-Louis, Stubbs, Brendon, Etchecopar-Etchart, Damien, Godin, Ophélia, Andrieu-Haller, Christelle, Berna, Fabrice, Aouizerate, Bruno, Capdevielle, Delphine, Chereau, Isabelle, Clauss-Kobayashi, Julie, Coulon, Nathalie, Dorey, Jean-Michel, Dubertret, Caroline, Leignier, Sylvain, Mallet, Jasmina, Misdrahi, David, Passerieux, Catherine, Pignon, Baptiste, Rey, Romain, Urbach, Mathieu, Llorca, Pierre-Michel, Schürhoff, Franck, Lançon, Christophe, Boyer, Laurent, Fond, Guillaume, Andre, M., Blanc, O., Bourguignon, E., Chereau-Boudet, I., Dassing, R., Esselin, A., Gabayet, F., Jarroir, M., Lacelle, D., Leboyer, M., Metairie, E., Michel, T., Petrucci, J., Peri, P., Portalier, C., Roman, C., Schorr, B., Szöke, A., Tessier, A., Wachiche, G., Zinetti-Bertschy, A., Fondation FondaMental [Créteil], Assistance Publique - Hôpitaux de Marseille (APHM), Centre d'études et de recherche sur les services de santé et la qualité de vie (CEReSS), Aix Marseille Université (AMU), Institute of Psychiatry, Psychology & Neuroscience, King's College London, King‘s College London, South London and Maudsley NHS Foundation Trust, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Henri Mondor [Créteil], Les Hôptaux universitaires de Strasbourg (HUS), CHU Strasbourg, Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie (NCPS), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Civil de Strasbourg, Centre hospitalier Charles Perrens [Bordeaux], Institut de Neurosciences cognitives et intégratives d'Aquitaine (INCIA), Université Bordeaux Segalen - Bordeaux 2-Université Sciences et Technologies - Bordeaux 1 (UB)-SFR Bordeaux Neurosciences-Centre National de la Recherche Scientifique (CNRS), Nutrition et Neurobiologie intégrée (NutriNeuro), Université de Bordeaux (UB)-Institut Polytechnique de Bordeaux-Ecole nationale supérieure de chimie, biologie et physique-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Institut Pascal (IP), Centre National de la Recherche Scientifique (CNRS)-Université Clermont Auvergne (UCA)-Institut national polytechnique Clermont Auvergne (INP Clermont Auvergne), Université Clermont Auvergne (UCA)-Université Clermont Auvergne (UCA), CHU Clermont-Ferrand, Les Hôpitaux Universitaires de Strasbourg (HUS), Centre Référent de Réhabilitation Psychosociale [CH Alpes Isère], Centre Hospitalier Alpes Isère, Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier le Vinatier [Bron], Hôpital Louis Mourier - AP-HP [Colombes], Institut de psychiatrie et neurosciences de Paris (IPNP - U1266 Inserm), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Centre Hospitalier de Versailles André Mignot (CHV), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, This work was funded by Hôpitaux Universitaires de Marseille (AP-HM)., CHU Henri Mondor, Hôpital Charles Perrens, Université Bordeaux Segalen - Bordeaux 2-Université Sciences et Technologies - Bordeaux 1-SFR Bordeaux Neurosciences-Centre National de la Recherche Scientifique (CNRS), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPC)
- Subjects
Adult ,Psychiatry ,Quality of life ,Public health ,[SDV]Life Sciences [q-bio] ,education ,General Medicine ,Biological Factors ,Psychiatry and Mental health ,Anti-Anxiety Agents ,Schizophrenia ,Humans ,Pharmacology (medical) ,Mental health ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Functioning ,Exercise ,human activities ,Biological Psychiatry ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Antipsychotic Agents - Abstract
International audience; The World Health Organization (WHO) recommends adults complete 150-300 min per week of moderate physical activity or 75-150 min of vigorous physical activity or an equivalent combination of both, to optimize health. To explore the factors associated with adequate MVPA in stabilized outpatients with schizophrenia. 425 stabilized outpatients were recruited in the national FACE-SZ cohort between 2015 and 2018 were evaluated with the International Physical Activity Questionnaire and a 1-day long standardized battery. We explored in multivariate analyses the clinical and pharmacological factors associated with MVPA (model 1) and the biological factors and patient-reported outcomes (model 2). Overall, only 86 (20.2%) of the 425 participants achieved the recommended MVPA threshold. In model 1, the adequate MVPA group was associated with younger age, mood stabilizers prescription and adherence to treatment, independent of sex, positive and depressive symptoms, first-generation antipsychotics prescription, anxiolytic medication, and akathisia. In model 2, adequate MVPA was associated with better glycemic and lipidic profile and better physical and psychological well-being, self-esteem, sentimental life, and resilience independently of age, sex, and current psychotic severity. The expert centers recommend the importance of promoting promote effective MVPA programs for stabilized patients with schizophrenia. Interventions studies suggest that MVPA may be a useful strategy to maximize physical and psychological well-being and self-esteem and potentially to prevent or manage metabolic disturbances.
- Published
- 2022
27. Représentations du travail et réinsertion professionnelle
- Author
-
Dubreucq, J., primary, Fernandez, E., additional, Lucas, Th., additional, Gabayet, F., additional, Revil, K., additional, and Roussel, C., additional
- Published
- 2016
- Full Text
- View/download PDF
28. Déstigmatiser grâce à la remédiation cognitive
- Author
-
Dubreucq, J., primary, Gabayet, F., additional, and Lucas, Th., additional
- Published
- 2016
- Full Text
- View/download PDF
29. The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort
- Author
-
Garosi, A., Sunhary de Verville, P., Etchecopar-Etchart, D., Richieri, R., Godin, O., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., Clauss-Kobayashi, J., Dorey, J., Dubertret, C., Coulon, N., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Szoke, A., Urbach, M., Leboyer, M., Llorca, P., Lançon, C., Boyer, L., Fond, G., Andre, M., Andrieu-Haller, C., Blanc, O., Bourguignon, E., Chereau-Boudet, I., Dassing, R., Esselin, A., Gabayet, F., Jarroir, M., Lacelle, D., Metairie, E., Michel, T., Petrucci, J., Pignon, B., Peri, P., Portalier, C., Roman, C., Schorr, B., Szöke, A., Tessier, A., Wachiche, G., Zinetti-Bertschy, A., Centre d'études et de recherche sur les services de santé et la qualité de vie (CEReSS), Aix Marseille Université (AMU), Université Paris-Est Créteil Val-de-Marne - Faculté de médecine (UPEC Médecine), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Fondation FondaMental [Créteil], Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Psychiatrie et Neurologie personnalisées [AP-HP Hôpital Henri-Mondor] (DHU PePsy), Hôpital Henri Mondor, Centre hospitalier Charles Perrens [Bordeaux], Nutrition et Neurobiologie intégrée (NutriNeuro), Université de Bordeaux (UB)-Institut Polytechnique de Bordeaux-Ecole nationale supérieure de chimie, biologie et physique-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Les Hôptaux universitaires de Strasbourg (HUS), CHU Strasbourg, Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie (NCPS), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Civil de Strasbourg, Centre Hospitalier le Vinatier [Bron], CEA-Direction des Energies (ex-Direction de l'Energie Nucléaire) (CEA-DES (ex-DEN)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Génétique moléculaire de la neurotransmission et des processus neurodégénératifs (LGMNPN), Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Sommeil, Addiction et Neuropsychiatrie [Bordeaux] (SANPSY), Université de Bordeaux (UB)-CHU de Bordeaux Pellegrin [Bordeaux]-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier de Versailles André Mignot (CHV), Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Institute of Genetics and Biotechnology, Szent István University, ANR-11-IDEX-0004,SUPER,Sorbonne Universités à Paris pour l'Enseignement et la Recherche(2011), ANR-10-COHO-0010,Psy-COH,FondaMental-Cohortes(2010), Hôpital Charles Perrens, and Sommeil, Attention et Neuropsychiatrie [Bordeaux] (SANPSY)
- Subjects
Psychiatry ,Quality of life ,Psychiatry and Mental health ,Depressive disorders ,[SDV]Life Sciences [q-bio] ,Schizophrenia ,Mood disorders ,Pharmacology (medical) ,Mental health ,General Medicine ,Biological Psychiatry - Abstract
International audience; Parent history of severe mental illness (PHSMI) may have long-term consequences in adult offspring due to genetic and early environmental factors in preliminary studies. To compare the outcomes associated in subjects with PHSMI to those in patients without PHSMI. The participants with schizophrenia and schizoaffective disorders were recruited in the ongoing FACE-SZ cohort at a national level (10 expert centers) and evaluated with a 1-day-long standardized battery of clinician-rated scales and patient-reported outcomes. PHSMI was defined as history of schizophrenia or bipolar disorders in at least one parent and was included as explanatory variable in multivariate models. Of the 724 included patients, 78 (10.7%) subjects were classified in the PHSMI group. In multivariate analyses, PHSMI patients had a better insight into schizophrenia and the need for treatment and reported more often childhood trauma history compared to patients without PHSMI. More specifically, those with paternal history of SMI reported more severe outcomes (increased childhood physical and emotional abuses, comorbid major depression and psychiatric hospitalizations). PHSMI is associated with increased risk of childhood trauma, major depressive disorder and psychiatric hospitalization and better insight in individuals with schizophrenia. Specific public health prevention programs for parents with SMI should be developed to help protect children from pejorative psychiatric outcomes. PHSMI may also explain in part the association between better insight and increased depression in schizophrenia.
- Published
- 2022
30. Comparison of three scales (BIS, SUMD and BCIS) for measuring insight dimensions and their evolution after one-year of follow-up: Findings from the FACE-SZ Cohort
- Author
-
Capdevielle, Delphine, primary, Norton, Joanna, additional, Aouizerate, Bruno, additional, Berna, Fabrice, additional, Chereau, Isabelle, additional, D'Amato, Thierry, additional, Dubertret, Caroline, additional, Dubreucq, Julien, additional, Fond, Guillaume, additional, C, Lançon, additional, Mallet, Jasmina, additional, Misdrahi, David, additional, Passerieux, Catherine, additional, Rey, Romain, additional, Schurhoff, Franck, additional, Urbach, Mathieu, additional, Llorca, Pierre-Michel, additional, Raffard, Stéphane, additional, Aouizerate, B., additional, Berna, F., additional, Blanc, O., additional, Capdevielle, D., additional, Chereau-Boudet, I., additional, Coulon, N., additional, D'Amato, T., additional, Dorey, J.M., additional, Dubertret, C., additional, Fond, G., additional, Gabayet, F., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Leboyer, M., additional, Llorca, P.M., additional, Mallet, J., additional, Metairie, E., additional, Misdrahi, D., additional, Passerieux, C., additional, Pignon, B., additional, Peri, P., additional, Portalier, C., additional, Rey, R., additional, Roman, C., additional, Schürhoff, F., additional, Szöke, A., additional, Urbach, M., additional, and Zinetti-Bertschy, A., additional
- Published
- 2021
- Full Text
- View/download PDF
31. Psychosis and Cannabis: Could a Hasty Diagnosis and Treatment of Schizophrenia be Harmful?
- Author
-
Mathieu Besnard, Nathalie Coulon, Zoé Boulot, and Franck Gabayet F
- Subjects
medicine.medical_specialty ,Psychosis ,biology ,business.industry ,General Medicine ,Cannabis use ,medicine.disease ,biology.organism_classification ,Psychotic episodes ,Substance-induced psychosis ,Schizophrenia ,medicine ,Cannabis ,Psychiatry ,business ,Young male ,Diagnosis of schizophrenia - Abstract
We describe a young male patient who questions his diagnosis of schizophrenia made 10 years ago, and whose clinical presentation and history seem in favour of cannabisinduced psychotic episodes. This case questions the risk of a hasty diagnosis when it comes to concomitant psychosis and cannabis use. This presentation raises medical, therapeutical, and ethical questions. With cannabis use rising globally, cases like this are bound to multiply. There are no evident clinical distinctions between psychosis such as schizophrenia, and cannabis-induced psychosis described in literature, nor evidence-based guidelines on the care patients should benefit from. Further research is therefore needed.
- Published
- 2021
32. Stigma resistance is associated with advanced stages of personal recovery in serious mental illness patients enrolled in psychiatric rehabilitation.
- Author
-
Dubreucq, J., Plasse, J., Gabayet, F., Faraldo, M., Blanc, O., Chereau, I., Cervello, S., Couhet, G., Demily, C., Guillard-Bouhet, N., Gouache, B., Jaafari, N., Legrand, G., Legros-Lafarge, E., Pommier, R., Quilès, C., Straub, D., Verdoux, H., Vignaga, F., and Massoubre, C.
- Subjects
PREVENTION of mental depression ,RESEARCH ,WELL-being ,EXECUTIVE function ,STATISTICS ,REHABILITATION centers ,CHRONIC diseases ,CONVALESCENCE ,MULTIVARIATE analysis ,SOCIAL stigma ,SATISFACTION ,PSYCHOEDUCATION ,REHABILITATION of people with mental illness ,PATIENTS' attitudes ,NEUROPSYCHOLOGICAL tests ,ATTITUDES toward illness ,DISABILITIES ,QUALITY of life ,STATISTICAL correlation ,ODDS ratio ,ATTITUDES toward disabilities ,COGNITIVE therapy - Abstract
Background: Stigma resistance (SR) is defined as one's ability to deflect or challenge stigmatizing beliefs. SR is positively associated with patient's outcomes in serious mental illness (SMI). SR appears as a promising target for psychiatric rehabilitation as it might facilitate personal recovery. Objectives: The objectives of the present study are: (i) to assess the frequency of SR in a multicentric non-selected psychiatric rehabilitation SMI sample; (ii) to investigate the correlates of high SR Methods: A total of 693 outpatients with SMI were recruited from the French National Centers of Reference for Psychiatric Rehabilitation cohort (REHABase). Evaluation included standardized scales for clinical severity, quality of life, satisfaction with life, wellbeing, and personal recovery and a large cognitive battery. SR was measured using internalized stigma of mental illness – SR subscale. Results: Elevated SR was associated with a preserved executive functioning, a lower insight into illness and all recovery-related outcomes in the univariate analyses. In the multivariate analysis adjusted by age, gender and self-stigma, elevated SR was best predicted by the later stages of personal recovery [rebuilding; p = 0.004, OR = 2.89 (1.36–4.88); growth; p = 0.005, OR = 2.79 (1.30–4.43)). No moderating effects of age and education were found. Conclusion: The present study has indicated the importance of addressing SR in patients enrolled in psychiatric rehabilitation. Recovery-oriented psychoeducation, metacognitive therapies and family interventions might improve SR and protect against insight-related depression. The effectiveness of psychiatric rehabilitation on SR and the potential mediating effects of changes in SR on treatment outcomes should be further investigated in longitudinal studies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. Psychosis and Cannabis: Could a Hasty Diagnosis and Treatment of Schizophrenia be Harmful?
- Author
-
Boulot, Zoé, primary, Gabayet F, Franck, additional, Besnard, Mathieu, additional, and Coulon, Nathalie, additional
- Published
- 2021
- Full Text
- View/download PDF
34. The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice
- Author
-
Godin, O., Boyer, L., Chereau, I., Andrianarisoa, M., Aouizerate, Bruno, Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Coulon, N., Danion, J.M., D’Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Jarroir, M., Lacelle, D., Lancon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vila, E., Vidailhet, P., Yazbek, H., Zinetti-Bertschy, A., Fondation FondaMental [Créteil], Image Science for Interventional Techniques (ISIT), Université d'Auvergne - Clermont-Ferrand I (UdA)-Clermont Université-Centre National de la Recherche Scientifique (CNRS), Nutrition et Neurobiologie intégrée (NutriNeuro), Université Bordeaux Segalen - Bordeaux 2-Institut National de la Recherche Agronomique (INRA)-Université Sciences et Technologies - Bordeaux 1-Institut Polytechnique de Bordeaux-Ecole nationale supérieure de chimie, biologie et physique, Université de Strasbourg (UNISTRA), Institut Européen des membranes (IEM), Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), IMRB - 'Neuropsychiatrie translationnelle' [Créteil] (U955 Inserm - UPEC), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Pôle de Psychiatrie [Hôpital Henri Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital H. Mondor - A. Chenevier, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Recherche Agronomique (INRA)-Université Sciences et Technologies - Bordeaux 1 (UB)-Institut Polytechnique de Bordeaux-Ecole nationale supérieure de chimie, biologie et physique, Université d'Auvergne - Clermont-Ferrand I (UdA)-Centre National de la Recherche Scientifique (CNRS)-Clermont Université, Université Bordeaux Segalen - Bordeaux 2-Université Sciences et Technologies - Bordeaux 1-Institut Polytechnique de Bordeaux-Ecole nationale supérieure de chimie, biologie et physique-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre National de la Recherche Scientifique (CNRS)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Université de Montpellier (UM), Institut d'Électronique et des Technologies du numéRique (IETR), Université de Nantes (UN)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées - Rennes (INSA Rennes), Institut National des Sciences Appliquées (INSA)-Université de Rennes (UNIV-RENNES)-Institut National des Sciences Appliquées (INSA)-CentraleSupélec-Centre National de la Recherche Scientifique (CNRS), Université de Bordeaux (UB)-Institut Polytechnique de Bordeaux-Ecole nationale supérieure de chimie, biologie et physique-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), and Centre National de la Recherche Scientifique (CNRS)-Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut de Chimie du CNRS (INC)-Université de Montpellier (UM)
- Subjects
Expert centre ,Inflammation ,Treatment ,Cognition ,Depression ,[SDV]Life Sciences [q-bio] ,Schizophrenia ,Metabolic syndrome - Abstract
International audience; Objectives - The present article is a synthesis of the first 10 years of follow-up of the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ) cohort. Methods - More than 700 community-dwelling stabilized subjects have been recruited and evaluated to date. The mean age was 32 years with 75 % males, the mean illness duration was 11 years, the mean age at illness onset was 21 years, the mean duration of untreated psychosis was 1.5 years and 55 % were current daily tobacco smokers. Results - The major findings of the FACE-SZ cohort may be summarized as follows: the metabolic syndrome is twice more frequent in schizophrenia as compared to the general population and is not correctly assessed and treated; cognitive disturbances have been found in benzodiazepine consumers and in patients with chronic low-grade peripheral inflammation; major depressive disorder (MDD) is a common current comorbid condition in about 20% of the subjects at the evaluation. MDD is associated with impaired quality of life and with increased nicotine dependency in SZ daily tobacco smokers. Improving depression and negative symptoms may be the most effective strategies to improve quality of life in schizophrenia; the duration of untreated psychosis is much longer in cannabis smokers and in subjects with an age at illness onset
- Published
- 2019
35. Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset
- Author
-
Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A., Boyer, L., Godin, O., Coulon, N., Richieri, R., Roux, P., and Schürhoff, F.
- Published
- 2018
- Full Text
- View/download PDF
36. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort
- Author
-
Fond , G., Boyer , L., Schürhoff , F., Berna , F., Godin , O., Bulzacka , E., Andrianarisoa , M., Brunel , L., Aouizerate , B., Capdevielle , D., Chereau , I., Coulon , N., d'Amato , T., Dubertret , C., Dubreucq , J., Faget , C., Lançon , C., Leignier , S., Mallet , J., Misdrahi , D., Passerieux , C., Rey , R., Schandrin , A., Urbach , M., Vidailhet , P., Llorca , P., Leboyer , M., Bazin , N., Blanc , O., Chereau-Boudet , I., Chesnoy-Servanin , G., Danion , M., Deloge , A., Denizot , H., Dorey , M., Fluttaz , C., Fonteneau , S., Gabayet , F., Giraud-Baro , E., Jarroir , M., Lacelle , D., Laouamri , H., Le Gloahec , T., Le Strat , Y., Metairie , E., Offerlin-Meyer , I., Peri , P., Pires , S., Portalier , C., Ramet , L., Roman , C., Tessier , A., Tronche , A., Vaillant , F., Vehier , A., Vila , E., Yazbek , H., Zinetti-Bertschy , A., CHU Pontchaillou [Rennes], Fondation FondaMental [Créteil], Institut Mondor de Recherche Biomédicale ( IMRB ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 ( UPEC UP12 ), Institut Européen des membranes ( IEM ), Centre National de la Recherche Scientifique ( CNRS ) -Ecole Nationale Supérieure de Chimie de Montpellier ( ENSCM ) -Université Montpellier 2 - Sciences et Techniques ( UM2 ) -Université de Montpellier ( UM ), Université Montpellier 1 ( UM1 ), Institut d'Electronique et de Télécommunications de Rennes ( IETR ), Université de Nantes ( UN ) -Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Institut National des Sciences Appliquées - Rennes ( INSA Rennes ) -CentraleSupélec-Centre National de la Recherche Scientifique ( CNRS ), Centre Hospitalier le Vinatier [Bron], Departement de Psychiatrie, Hôpital de la Conception [CHU - APHM] ( LA CONCEPTION ), Génétique moléculaire de la neurotransmission et des processus neurodégénératifs ( LGMNPN ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Centre National de la Recherche Scientifique ( CNRS ), ONERA - The French Aerospace Lab ( Toulouse ), ONERA, Neuro-Psycho Pharmacologie des Systèmes Dopimanégiques sous-corticaux - Clermont Auvergne ( NPsy-Sydo ), CHU Clermont-Ferrand-Université Clermont Auvergne ( UCA ), Franche-Comté Électronique Mécanique, Thermique et Optique - Sciences et Technologies ( FEMTO-ST ), Université de Technologie de Belfort-Montbeliard ( UTBM ) -Ecole Nationale Supérieure de Mécanique et des Microtechniques ( ENSMM ) -Centre National de la Recherche Scientifique ( CNRS ) -Université de Franche-Comté ( UFC ), Département des maladies infectieuses, Institut de Veille Sanitaire (INVS), Laboratoire de Physique Nucléaire et de Hautes Énergies ( LPNHE ), Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Institut National de Physique Nucléaire et de Physique des Particules du CNRS ( IN2P3 ) -Université Paris Diderot - Paris 7 ( UPD7 ) -Centre National de la Recherche Scientifique ( CNRS ), Techniques of Informatics and Microelectronics for integrated systems Architecture ( TIMA ), Université Joseph Fourier - Grenoble 1 ( UJF ) -Institut polytechnique de Grenoble - Grenoble Institute of Technology ( Grenoble INP ) -Institut National Polytechnique de Grenoble ( INPG ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Grenoble Alpes ( UGA ), Centre Hospitalier d'Annecy, Centre hospitalier d'Annecy, IHU-LIRYC, and Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux]
- Subjects
[ SDV.NEU.PC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior ,[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences ,[ SDV.NEU.NB ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,[ SCCO.NEUR ] Cognitive science/Neuroscience ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2018
37. Relationship between childhood trauma and level of insight in schizophrenia: A path-analysis in the national FACE-SZ dataset
- Author
-
Pignon, Baptiste, primary, Lajnef, Mohamed, additional, Godin, Ophélia, additional, Geoffray, Marie-Maud, additional, Rey, Romain, additional, Mallet, Jasmina, additional, Dubertret, Caroline, additional, Roux, Paul, additional, Passerieux, Christine, additional, Marulaz, Laurent, additional, Brunel, Lore, additional, Dubreucq, Julien, additional, Leignier, Sylvain, additional, Capdevielle, Delphine, additional, André, Myrtille, additional, Aouizerate, Bruno, additional, Misdrahi, David, additional, Berna, Fabrice, additional, Vidailhet, Pierre, additional, Chereau, Isabelle, additional, Llorca, Pierre-Michel, additional, Fond, Guillaume, additional, Lançon, Christophe, additional, Leboyer, Marion, additional, Schürhoff, Franck, additional, Andrianarisoa, M.D., additional, Aouizerate, B., additional, Berna, F., additional, Blanc, O., additional, Brunel, L., additional, Bulzacka, E., additional, Capdevielle, D., additional, Chereau-Boudet, I., additional, Chesnoy-Servanin, G., additional, Danion, Jm, additional, D'Amato, T., additional, Deloge, A., additional, Delorme, C., additional, Denizot, H., additional, Dorey, J.M., additional, Dubertret, C., additional, Dubreucq, J., additional, Faget, C., additional, Fluttaz, C., additional, Fond, G., additional, Fonteneau, S., additional, Gabayet, F., additional, Giraud-Baro, E., additional, Hardy-Bayle, M.C., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Leboyer, M., additional, Le Gloahec, T., additional, Le Strat, Y., additional, Llorca, P.M., additional, Mallet, J., additional, Metairie, E., additional, Misdrahi, D., additional, Offerlin-Meyer, I., additional, Passerieux, C., additional, Peri, P., additional, Pires, S., additional, Portalier, C., additional, Rey, R., additional, Roman, C., additional, Sebilleau, M., additional, Schandrin, A., additional, Schurhoff, F., additional, Tessier, A., additional, Tronche, Am, additional, Urbach, M., additional, Vaillant, F., additional, Vehier, A., additional, Vidailhet, P., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2019
- Full Text
- View/download PDF
38. Centres Experts Schizophrénie, un outil pour le soin et la recherche : retour sur 10 ans d’expérience
- Author
-
Schürhoff, F., primary, Fond, G., additional, Berna, F., additional, Bulzacka, E., additional, Godin, O., additional, Boyer, L., additional, Misdrahi, D., additional, Andrianarisoa, M., additional, Brunel, L., additional, Coulon, N., additional, Aouizerate, B., additional, Capdevielle, D., additional, Chereau, I., additional, D’Amato, T., additional, Dubertret, C., additional, Dubreucq, J., additional, Faget, C., additional, Gabayet, F., additional, Mallet, J., additional, Rey, R., additional, Lancon, C., additional, Passerieux, C., additional, Schandrin, A., additional, Urbach, M., additional, Vidailhet, P., additional, Leboyer, M., additional, Llorca, P.M., additional, Bazin, N., additional, Blanc, O., additional, Chereau-Boudet, I., additional, Chesnoy-Servanin, G., additional, Danion, J.M., additional, Deloge, A., additional, Delorme, C., additional, Denizot, H., additional, Dorey, J.M., additional, Fluttaz, C., additional, Fonteneau, S., additional, Giraud-Baro, E., additional, Jarroir, M., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Le Gloahec, T., additional, Le Strat, Y., additional, Metairie, E., additional, Offerlin-Meyer, I., additional, Peri, P., additional, Pires, S., additional, Portalier, C., additional, Ramet, L., additional, Roman, C., additional, Schürhoff, F., additional, Tessier, A., additional, Tronche, A.M., additional, Vaillant, F., additional, Vehier, A., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2019
- Full Text
- View/download PDF
39. A multi-dimensional approach to the relationship between insight and aggressiveness in schizophrenia: Findings from the FACE-SZ cohort
- Author
-
Schandrin, A., primary, Norton, J., additional, Raffard, S., additional, Aouizerate, B., additional, Berna, F., additional, Brunel, L., additional, Chereau-Boudet, I., additional, D'Amato, T., additional, Denizot, H., additional, Dubertret, C., additional, Dubreucq, J., additional, Faget, C., additional, Fond, G., additional, Gabayet, F., additional, Llorca, P.M., additional, Mallet, J., additional, Misdrahi, D., additional, Passerieux, C., additional, Rey, R., additional, Schurhoff, F., additional, Urbach, M., additional, Bonnet, S., additional, Capdevielle, D., additional, Andrianarisoa, M., additional, Bazin, N., additional, Blanc, O., additional, Bulzacka, E., additional, Chesnoy-Servanin, G., additional, Danion, J.M., additional, Deloge, A., additional, Delorme, C., additional, Dorey, J.M., additional, Fluttaz, C., additional, Fonteneau, S., additional, Giraud-Baro, E., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Leboyer, M., additional, Le Gloahec, T., additional, Le Strat, Y., additional, Metairie, E., additional, Offerlin-Meyer, I., additional, Peri, P., additional, Pires, S., additional, Portalier, C., additional, Ramet, L., additional, Rey, L., additional, Roman, C., additional, Schandrin, A., additional, Schürhoff, F., additional, Tessier, A., additional, Tronche, A.M., additional, Vaillant, F., additional, Vehier, A., additional, Vidailhet, P., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2019
- Full Text
- View/download PDF
40. Centres Experts Schizophrénie, un outil pour le soin et la recherche : retour sur 10 ans d’expérience
- Author
-
Schürhoff, F., Fond, G., Berna, F., Bulzacka, E., Godin, O., Boyer, L., Misdrahi, D., Andrianarisoa, M., Brunel, L., Coulon, N., Aouizerate, B., Capdevielle, D., Chereau, I., D’Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Mallet, J., Rey, R., Lancon, C., Passerieux, C., Schandrin, A., Urbach, M., Vidailhet, P., Leboyer, M., Llorca, P.M., Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Coulon, N., Danion, J.M., D’Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Jarroir, M., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., and Zinetti-Bertschy, A.
- Abstract
Le présent article propose de faire un retour sur les 10 ans d’expérience du réseau national des 10 centres experts schizophrénie Français, à travers une revue des principales publications scientifiques qui en sont issues.
- Published
- 2024
- Full Text
- View/download PDF
41. Self-stigma in serious mental illness and autism spectrum disorder: Results from the REHABase national psychiatric rehabilitation cohort.
- Author
-
Dubreucq, J., Plasse, J., Gabayet, F., Faraldo, M., Blanc, O., Chereau, I., Cervello, S., Couhet, G., Demily, C., Guillard-Bouhet, N., Gouache, B., Jaafari, N., Legrand, G., Legros-Lafarge, E., Pommier, R., Quilès, C., Straub, D., Verdoux, H., Vignaga, F., and Massoubre, C.
- Subjects
AUTISM spectrum disorders ,MENTAL illness ,LIFE satisfaction ,REHABILITATION ,ATTEMPTED suicide - Abstract
Background. Self-stigma is a major issue in serious mental illness (SMI) and is negatively associated with patient outcomes. Most studies have been conducted in schizophrenia (SZ). Less is known about self-stigma in other SMI and autism spectrum disorder (ASD). The objectives of this study are: (i) to assess the frequency of self-stigma in a multicentric nonselected psychiatric rehabilitation SMI and ASD sample; and (ii) to investigate the correlates of elevated self-stigma in different SMI conditions and in ASD. Methods. A total of 738 SMI or ASD outpatients were recruited from the French National Centers of Reference for Psychiatric Rehabilitation cohort (REHABase). Evaluations included sociodemographic data, illness characteristics, and standardized scales for clinical severity, quality of life, satisfaction with life, wellbeing, personal recovery, a large cognitive battery, and daily functioning assessment. Results. 31.2%of the total sample had elevated self-stigma. The highest prevalence (43.8%) was found in borderline personality disorder and the lowest (22.2%) in ASD. In the multivariate analysis, elevated self-stigma was best predicted by early stages of personal recovery (moratorium, p = 0.001, OR = 4.0 [1.78-8.98]; awareness, p = 0.011, OR = 2.87 [1.28-6.44]), history of suicide attempt (p = 0.001, OR = 2.27 [1.37-3.76]), insight (p = 0.002, OR = 1.22 [1.08-1.38]), wellbeing (p = 0.037, OR = 0.77 [0.60-0.98]), and satisfaction with interpersonal relationships (p < 0.001, OR = 0.85 [0.78-0.93]). Conclusions. The present study has confirmed the importance of addressing self-stigma in SMI and ASD patients enrolled in psychiatric rehabilitation. The effectiveness of psychiatric rehabilitation on self-stigma and the potential mediating effects of changes in self-stigma on treatment outcomes should be further investigated. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
42. 15 - Représentations du travail et réinsertion professionnelle
- Author
-
Dubreucq, J., Fernandez, E., Lucas, Th., Gabayet, F., Revil, K., and Roussel, C.
- Published
- 2016
- Full Text
- View/download PDF
43. 10 - Déstigmatiser grâce à la remédiation cognitive
- Author
-
Dubreucq, J., Gabayet, F., and Lucas, Th.
- Published
- 2016
- Full Text
- View/download PDF
44. Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset
- Author
-
Fond, G., primary, Boyer, L., additional, Andrianarisoa, M., additional, Godin, O., additional, Brunel, L., additional, Bulzacka, E., additional, Coulon, N., additional, Llorca, P.M., additional, Berna, F., additional, Aouizerate, B., additional, Capdevielle, D., additional, D'Amato, T., additional, Dubertret, C., additional, Dubreucq, J., additional, Faget, C., additional, Gabayet, F., additional, Mallet, J., additional, Misdrahi, D., additional, Rey, R., additional, Richieri, R., additional, Roux, P., additional, Passerieux, C., additional, Schandrin, A., additional, Tronche, A.M., additional, Vidailhet, P., additional, Leboyer, M., additional, Schürhoff, F., additional, Blanc, O., additional, Chereau-Boudet, I., additional, Chesnoy-Servanin, G., additional, Danion, J.M., additional, Deloge, A., additional, Delorme, C., additional, Denizot, H., additional, Dorey, J.M., additional, Fluttaz, C., additional, Fond, G., additional, Fonteneau, S., additional, Giraud-Baro, E., additional, Hardy-Bayle, M.C., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Le Gloahec, T., additional, Le Strat, Y., additional, Metairie, E., additional, Offerlin-Meyer, I., additional, Peri, P., additional, Pires, S., additional, Portalier, C., additional, Roman, C., additional, Sebilleau, M., additional, Schurhoff, F., additional, Tessier, A., additional, Urbach, M., additional, Vaillant, F., additional, Vehier, A., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2018
- Full Text
- View/download PDF
45. The World Health Organization (WHO) dataset for guiding suicide prevention policies: A 3-decade French national survey
- Author
-
Godin, O., Gaman, A., Richieri, R., Vidalhet, P., Girerd, N., Aouizerate, B., Berna, F., Blanc, O., Bulzacka, E., Capdevielle, D., Chereau, I., Chesnoy-Servanin, G., Danion, M., d'Amato, T., Deloge, A., Delorme, C., Denizot, H., Depradier, M., Dorey, M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M., Lacelle, D., Lancon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vila, E., Yazbek, H., Zinetti-Bertschy, A., de Chazeron, I., Pereira, B., Chéreau-Boudet, I., Durif, F., Lemaire, J., Brousse, B., Ulla, M., Derost, P., Debilly, B., Llorca, M., Fond, Guillaume, Zendjidjian, Xavier, Boucekine, Mohamed, Brunel, Lore, Llorca, Pierre-Michel, Boyer, Laurent, Fondation FondaMental [Créteil], Departement de Psychiatrie, Hôpital de la Conception [CHU - APHM] (LA CONCEPTION ), Neuropsychologie Cognitive et Physiopathologie de la Schizophrénie, Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Civil de Strasbourg, Biostatistiques santé, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup (VAS)-Centre National de la Recherche Scientifique (CNRS), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Montpellier 1 (UM1), Centre Hospitalier le Vinatier [Bron], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud ), Hopital Louis Mourier - AP-HP [Colombes], Institut de Recherches sur les lois Fondamentales de l'Univers (IRFU), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, ONERA - The French Aerospace Lab [Toulouse], ONERA, Centre Hospitalier d'Annecy, Centre hospitalier d'Annecy, IHU-LIRYC, Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux], Neuro-Psycho Pharmacologie des Systèmes Dopimanégiques sous-corticaux - Clermont Auvergne (NPsy-Sydo), CHU Clermont-Ferrand-Université Clermont Auvergne (UCA), Biostatistiques, Inferential, Laboratoire de Chimie Physique D'Orsay (LCPO), Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS), Institut de Biologie du Développement de Marseille (IBDM), Aix Marseille Université (AMU)-Collège de France (CdF)-Centre National de la Recherche Scientifique (CNRS), Université d'Auvergne - Clermont-Ferrand I (UdA), Assistance Publique - Hôpitaux de Marseille (APHM), Centre d'études et de recherche sur les services de santé et la qualité de vie (CEReSS), Aix Marseille Université (AMU), Laboratoire de l'intégration, du matériau au système (IMS), Université Sciences et Technologies - Bordeaux 1-Institut Polytechnique de Bordeaux-Centre National de la Recherche Scientifique (CNRS), Santé Publique et maladies Chroniques : Qualité de vie Concepts, Usages et Limites, Déterminants (SPMC), and Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)
- Subjects
Gerontology ,Male ,Suicide Prevention ,medicine.medical_specialty ,Time Factors ,Adolescent ,Databases, Factual ,[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,Population ,Poison control ,World Health Organization ,Suicide prevention ,Sex Factors ,Surveys and Questionnaires ,Health care ,Medicine ,Humans ,Mortality ,education ,Health policy ,ComputingMilieux_MISCELLANEOUS ,Aged ,education.field_of_study ,[SDV.NEU.PC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Psychology and behavior ,business.industry ,Mortality rate ,Public health ,Health Policy ,[SCCO.NEUR]Cognitive science/Neuroscience ,Age Factors ,[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences ,Middle Aged ,Psychiatry and Mental health ,Clinical Psychology ,Suicide ,Health promotion ,Socioeconomic Factors ,Female ,France ,business ,Demography - Abstract
Background Public health policies aim to prevent suicide in the general population. Assessing their effectiveness is required to further guide public health policies. The present article focuses on the French paradox. The French health care system was classified as the best in the world according the World Health Organization (WHO). However, suicide rates in France remain high compared to other European countries. The aim of the present article was to analyze (i) the evolution of suicide Age-Standardized Death (ASDRs) in France during the last three decades and the associations with socio-economic parameters and (ii) to understand which populations may specifically benefit from further targeted suicide prevention policies. Methods The database of the World Health Organization (WHO), freely available, was explored in April 2015. ASDRs were calculated each year by ratio between the number of deaths by suicide and the total population (per 100,000 inhabitants). Number of deaths by gender and age were also analyzed. Results Overall, ASDR suicide has decreased since 1987 in France (−32.8% between 1987 and 2010). However, France kept the same rank (10/26) when compared to other European countries between 1987 and 2010. The relative burden of suicide in all-causes mortality increased during the same period (+28.2%) while the total number of deaths by suicide increased only slightly (+3.9%). More specifically, the number of deaths by suicide increased substantially in [35–54] years old (+40%) and 75+ years old (+27%) males, and in [35–54] (+41%) years old females. Between 2000 and 2010, suicide rates significantly decreased when yearly mean income increased, and when general and psychiatric care beds decreased. Conclusion Although ASDR suicide has decreased in France since 1987, this decline is quite modest when considering its universal access to care, the prevention of depression and suicide public policies. Suicide prevention public policies should focus on evaluation and improvement of prevention and care in the [35–54] years old population, and in the males aged 75+.
- Published
- 2015
46. Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort
- Author
-
Godin, O., primary, Leboyer, M., additional, Schürhoff, F., additional, Boyer, L., additional, Andrianarisoa, M., additional, Brunel, L., additional, Bulzacka, E., additional, Aouizerate, B., additional, Berna, F., additional, Capdevielle, D., additional, D'Amato, T., additional, Denizot, H., additional, Dubertret, C., additional, Dubreucq, J., additional, Faget, C., additional, Gabayet, F., additional, Llorca, P.M., additional, Mallet, J., additional, Misdrahi, D., additional, Passerieux, C., additional, Rey, R., additional, Richieri, R., additional, Schandrin, A., additional, Urbach, M., additional, Vidailhet, P., additional, Costagliola, D., additional, Fond, G., additional, Blanc, O., additional, Chereau-Boudet, I., additional, Chesnoy-Servanin, G., additional, Danion, J.M., additional, Deloge, A., additional, Delorme, C., additional, Dorey, J.M., additional, Fluttaz, C., additional, Fonteneau, S., additional, Giraud-Baro, E., additional, Hardy-Bayle, M.C., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Le Gloahec, T., additional, Le Strat, Y., additional, Metairie, E., additional, Offerlin-Meyer, I., additional, Peri, P., additional, Pires, S., additional, Portalier, C., additional, Roman, C., additional, Sebilleau, M., additional, Tessier, A., additional, Tronche, A.M., additional, Vaillant, F., additional, Vehier, A., additional, Vilain, J., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2017
- Full Text
- View/download PDF
47. Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort
- Author
-
Mallet, J., primary, Le Strat, Y., additional, Schürhoff, F., additional, Mazer, N., additional, Portalier, C., additional, Andrianarisoa, M., additional, Aouizerate, B., additional, Berna, F., additional, Brunel, L., additional, Capdevielle, D., additional, Chereau, I., additional, D'Amato, T., additional, Denizot, H., additional, Dubreucq, J., additional, Faget, C., additional, Gabayet, F., additional, Lançon, C., additional, Llorca, P.M., additional, Misdrahi, D., additional, Rey, R., additional, Roux, P., additional, Schandrin, A., additional, Urbach, M., additional, Vidailhet, P., additional, Fond, G., additional, Dubertret, C., additional, Bazin, N., additional, Blanc, O., additional, Bulzacka, E., additional, Chereau-Boudet, I., additional, Chesnoy-Servanin, G., additional, Danion, J.M., additional, Deloge, A., additional, Delorme, C., additional, Dorey, J.M., additional, Fluttaz, C., additional, Fonteneau, S., additional, Giraud-Baro, E., additional, Lacelle, D., additional, Laouamri, H., additional, Leboyer, M., additional, Le Gloahec, T., additional, Mallet, J., additional, Metairie, E., additional, Offerlin-Meyer, I., additional, Passerieux, C., additional, Peri, P., additional, Pires, S., additional, Ramet, L., additional, Roman, C., additional, Tessier, A., additional, Tronche, A.M., additional, Vaillant, F., additional, Vehier, A., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2017
- Full Text
- View/download PDF
48. Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset
- Author
-
Berna, F., primary, Misdrahi, D., additional, Boyer, L., additional, Aouizerate, B., additional, Brunel, L., additional, Capdevielle, D., additional, Chereau, I., additional, Danion, J.M., additional, Dorey, J.M., additional, Dubertret, C., additional, Dubreucq, J., additional, Faget, C., additional, Gabayet, F., additional, Lancon, C., additional, Mallet, J., additional, Rey, R., additional, Passerieux, C., additional, Schandrin, A., additional, Schurhoff, F., additional, Tronche, A.M., additional, Urbach, M., additional, Vidailhet, P., additional, Llorca, P.M., additional, Fond, G., additional, Berna, F., additional, Blanc, O., additional, Bulzacka, E., additional, Chereau-Boudet, I., additional, Chesnoy-Servanin, G., additional, D'Amato, T., additional, Deloge, A., additional, Delorme, C., additional, Denizot, H., additional, De Pradier, M., additional, Fluttaz, C., additional, Fonteneau, S., additional, Giraud-Baro, E., additional, Hardy-Bayle, M.C., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Leboyer, M., additional, Le Gloahec, T., additional, Le Strat, Y., additional, Metairie, E., additional, Offerlin-Meyer, I., additional, Peri, P., additional, Pires, S., additional, Portalier, C., additional, Roman, C., additional, Sebilleau, M., additional, Tessier, A., additional, Vaillant, F., additional, Vehier, A., additional, Vilain, J., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2015
- Full Text
- View/download PDF
49. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
- Author
-
Fond, Guillaume, Berna, F., Boyer, L., Godin, O., Brunel, L., Andrianarisoa, M., Aouizerate, B., Capdevielle, D., Chereau, I., Danion, J. M., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Le Gloahec, T., Llorca, P. M., Mallet, J., Misdrahi, D., Rey, R., and Richieri, R.
- Subjects
BENZODIAZEPINES ,VERBAL learning ,TRANQUILIZING drugs ,COGNITIVE ability ,MULTIVARIATE analysis - Abstract
Objective: The effect of benzodiazepine long-term administration (BLTA) in cognitive functioning of subjects with schizophrenia (SZ) has been partially explored to date. The objective was to assess BLTA-associated cognitive impairment with a comprehensive cognitive battery in a non-selected multicentric/national community-dwelling sample of stabilized SZ subjects. Method: 407 community-dwelling stabilized SZ subjects were consecutively included in the FondaMental Academic Centers of Expertise for Schizophrenia Cohort (FACE-SZ). Patients taking daily benzodiazepine were defined as BLTA+ as all patients examined by the Expert Center were clinically stabilized and under stable dose of treatment for at least 3 months. Each patient has been administered a 1-day long comprehensive cognitive battery (including The National Adult Reading Test, the Wechsler Adult Intelligence Scale, the Trail Making Test, the California Verbal Learning Test, the Doors test, and The Continuous Performance Test-Identical Pairs). Results: In the multivariate analyses, results showed that BLTA was associated with impaired attention/working memory (OR 0.60, 95% confidence interval 0.42-0.86; p = 0.005) independently of socio-demographic variables and illness characteristics. Verbal and performance current IQ-[respectively, OR 0.98, 95% CI (0.96;0.99), p = 0.016 and 0.98, 95% CI(0.97;0.99), p = 0.034] but not premorbid IQ-( p > 0.05) have been associated with BLTA in a multivariate model including the same confounding variables. Conclusion: BLTA is associated with impaired attention/working memory in schizophrenia. The BLTA benefit/risk ratio should be regularly reevaluated. Alternative pharmacological and non-pharmacological strategies for comorbid anxiety disorders and sleep disorders should be preferred when possible. It seems reasonable to withdraw BLTA before the start of cognitive remediation therapy, as soon as possible, to improve the effectiveness of this therapy. Limits: the delay between the last benzodiazepine intake and testing, as well as the specific class of benzodiazepines (long half-life vs. short half-life), and the number of benzodiazepine daily intakes have not been recorded in the present study. The precise motive for BLTA prescription and sleep disturbances have not been reported, which is a limit for the interpretation of the present results. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
50. Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort
- Author
-
Godin, O., primary, Leboyer, M., additional, Gaman, A., additional, Aouizerate, B., additional, Berna, F., additional, Brunel, L., additional, Capdevielle, D., additional, Chereau, I., additional, Dorey, J.M., additional, Dubertret, C., additional, Dubreucq, J., additional, Faget, C., additional, Gabayet, F., additional, Le Strat, Y., additional, Llorca, P.M., additional, Misdrahi, D., additional, Rey, R., additional, Richieri, R., additional, Passerieux, C., additional, Schandrin, A., additional, Schürhoff, F., additional, Urbach, M., additional, Vidalhet, P., additional, Girerd, N., additional, Fond, G., additional, Blanc, O., additional, Bulzacka, E., additional, Chereau-Boudet, I., additional, Chesnoy-Servanin, G., additional, Danion, J.M., additional, D'Amato, T., additional, Deloge, A., additional, Delorme, C., additional, Denizot, H., additional, Depradier, M., additional, Fluttaz, C., additional, Fonteneau, S., additional, Giraud-Baro, E., additional, Hardy-Bayle, M.C., additional, Lacelle, D., additional, Lançon, C., additional, Laouamri, H., additional, Le Gloahec, T., additional, Metairie, E., additional, Offerlin-Meyer, I., additional, Peri, P., additional, Pires, S., additional, Portalier, C., additional, Roman, C., additional, Sebilleau, M., additional, Tessier, A., additional, Tronche, A.M., additional, Vaillant, F., additional, Vehier, A., additional, Vidailhet, P., additional, Vilà, E., additional, Yazbek, H., additional, and Zinetti-Bertschy, A., additional
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.